Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Working at SillaJen

Zippia score 4.4

Overview

Salary

Reviews

HistoryCEO & Executives

SillaJen overview

Industry
Biopharmaceuticals
Headquarters
Employees
100
Founded in
2003
Organization type
Public
SillaJen, Inc. is a South Korean based biotechnology company headquartered in Busan South Korea, with satellite offices in Seoul South Korea and Financial District, San Francisco. The company is focused on the development and commercialization of oncolytic immunotherapy products using the SOLVE™ platform, including its lead product Pexa-Vec, which is currently in Phase 3 trials for the treatment of advanced primary liver cancer. 2003. Jennerex, Inc. (San Francisco, USA) was established. 2014. SillaJen acquires Jennerex, Inc. 2015. In April 2015. SillaJen reached agreement with the US FDA on a Special Protocol Assessment (SPA) for multinational Phase 3 clinical trial of Pexa-Vec in Advanced Liver Cancer. 2015. In October 2015, SillaJen is selected as the major developer for the Government project of “Global State-of-the-art technology development for biomedical products." 2016. In January 2016, SillaJen announces first patient randomized in multinational Phase 3 trial for Pexa-Vec in Advanced Liver Cancer. In December 2016. SillaJen is listed on KOSDAQ market in South Korea. 2017. In may 2017, Sillajen signs collaborative agreement with Regeneron Pharmaceuticals for development of combination therapy with Pexa-Vec and immune checkpoint inhibitors. In July 2017, SillaJen received approval from the China CFDA to commence phase 3 clinical trial for Pexa-Vec in liver cancer. In Aug 2017, Sillajen signs collaborative agreement with the National Cancer Institute for development of combination therapy with Pexa-Vec and immune checkpoint inhibitors.
SillaJen is a small pharmaceutical company based in San Francisco, CA with only 100 employees.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

SillaJen employee reviews

Be the first to review!

Do you work at SillaJen?

Help job seekers learn about working at SillaJen

On this page

Be the first to review SillaJen

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at SillaJen?

The team at SillaJen

  • The founders of SillaJen is Tae-Ho Hwang.
  • The key people at SillaJen are Eun Sang Moon and Tae-Ho Hwang.
Key people
Eun Sang Moon
Tae-Ho Hwang

SillaJen rankings

SillaJen is ranked #38 on the Best Pharmaceutical companies to work for in California list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

SillaJen salaries

Average SillaJen salary
$68,581
yearly
$32.97 hourly
Updated March 14, 2024

Rate SillaJen's fairness in compensating employees.

Zippia waving zebra

Do you work at SillaJen?

Does SillaJen actively promote diversity and inclusion?

SillaJen financial performance

8.8
Performance score

Are you an executive, HR leader, or brand manager at SillaJen?

Claiming and updating your company profile on Zippia is free and easy.

SillaJen FAQs

Have more questions? See all answers to common company questions.

Search for jobs

Cities with SillaJen jobs

Related companies

Related company jobs

Related company salaries

    Updated March 14, 2024

    Zippia gives an in-depth look into the details of SillaJen, including salaries, political affiliations, employee data, and more, in order to inform job seekers about SillaJen. The employee data is based on information from people who have self-reported their past or current employments at SillaJen. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by SillaJen. The data presented on this page does not represent the view of SillaJen and its employees or that of Zippia.

    SillaJen may also be known as or be related to Jennerex , Inc, SillaJen, SillaJen, Inc., Sillajen Inc. and Sillajen Usa, Inc.